The company manufactures and markets synthetic blended yarns, cotton yarns, and polypropylene multifilament yarns used in the apparel and home textile industries.
The company operates in a highly fragmented, commodity-driven textile market with no evidence of pricing power, as reflected by deeply negative net margins and declining revenue. High ROCE figures are distorted by massive exceptional gains from debt restructuring rather than operational efficiency.
Capital allocation has been poor, characterized by a failure to maintain plant and equipment due to liquidity constraints, leading to a court-mandated insolvency resolution process and the liquidation of core manufacturing assets.
The investment collapsed after the NCLAT ruled in favor of the Bank of Baroda, overturning the insolvency resolution plan and plunging the company back into liquidation proceedings. Without core manufacturing assets—which were sold off to satisfy immediate debts—the company became a hollow shell incapable of generating operational cash flow. The family-dominated board failed to pivot the business model, and the remaining capital was drained by ongoing litigation costs and related-party obligations, leaving equity holders with nothing but a delisted entity.
RichFakir rates Shree Rajasthan Syntex Ltd's business quality as poor — 32/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Shree Rajasthan Syntex Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Shree Rajasthan Syntex Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Shree Rajasthan Syntex Ltd's fair value is about ₹0 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →